Related Experiment Video
Updated: Jun 22, 2026
09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives.
R I Aqeilan1, G A Calin, C M Croce
1The Lautenberg Center for General and Tumor Immunology, Hebrew University-Hadassah Medical School, Institute for Medical Research Israel-Canada, Ein Karem, P.O. Box 12272, Jerusalem 91120, Israel. aqeilan@cc.huji.ac.il
Cell Death and Differentiation
|June 6, 2009
Summary
The miR-15/16 cluster microRNAs (miRNAs) suppress tumors by inhibiting cell growth and promoting cancer cell death. Their down-regulation is linked to cancers like chronic lymphocytic leukemia (CLL).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) encoded by the miR-15/16 cluster function as tumor suppressors.
- These miRNAs inhibit cell proliferation, induce apoptosis, and suppress tumorigenicity.
- They target oncogenes such as BCL2, MCL1, CCND1, and WNT3A.
Purpose of the Study:
- To review the discovery and functions of miR-15/16 cluster miRNAs.
- To summarize their clinical relevance in various cancers, with a focus on CLL.
Main Methods:
- Literature review of studies on miR-15/16 cluster miRNAs.
- Analysis of miRNA expression data in cancer tissues.
- Examination of miRNA target genes and their roles in cancer pathways.
Main Results:
- Down-regulation of miR-15a and miR-16-1 is observed in chronic lymphocytic lymphoma (CLL), pituitary adenomas, and prostate carcinoma.
- These miRNAs play a critical role in regulating cell growth and apoptosis.
- Targeting of key oncogenes by miR-15/16 miRNAs contributes to their tumor-suppressive function.
Conclusions:
- The miR-15/16 cluster miRNAs are crucial tumor suppressors with significant clinical relevance.
- Their dysregulation contributes to the development and progression of several cancers, notably CLL.
- These miRNAs represent potential therapeutic targets for cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...